Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2002

View Archived Issues

Treatment with statins reported not to be related to a higher risk for breast cancer

DT388-GM-CSF is effective against refractory acute myeloid leukemia but causes liver injury

Thalidomide reported to be effective in the short-term treatment of symptomatic IBD

Soybean phytosterols induce hypocholesterolemic effects in young adult men

STO-609, a potent and selective CaM-KK inhibitor synthesized at Sumitomo

HGF, a rapid diagnostic marker and preventative treatment for acute renal rejection

Buprenorphine transdermal therapeutic system is effective in relieving chronic pain

Chromium picolinate improves carbohydrate and lipid metabolism in obese hyperinsulinemic rats

Novel HDAC inhibitors in early development at Roche

Novel 5-HT2C modulators prepared and tested at Roche and Vernalis

New tachykinin NK1 antagonists identified by AstraZeneca researchers

New muscarinic antagonists and their use in cognitive and neurodegenerative disorders

Bayer claims new thyroid-like compounds for lipoprotein disorders

Latest FDA approval for Kytril is for prevention and treatment of postoperative nausea and vomiting

Myriad Genetics files IND with FDA for new Alzheimer's treatment

Clinical trial commences for squalamine in treatment of AMD

Novel nonprostanoid EP4 antagonist prepared and tested at GSK

In vitro and in vivo studies on bone-healing agent CP-533536 reported at ACS

FDA issues non approval letter for Helicide

New 5-HT2C agonist and its use in erectile dysfunction discussed at ACS meeting

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...